📈 Multi-Signal Breakout Setup on a Fundamentally Resilient Pharma Stock

🔍 Technical + Fundamental Confluence Analysis 1️⃣ Price Structure & Elliott Wave Perspective The chart of Glenmark Pharmaceuticals Limited reflects a mature corrective phase followed by a fresh impulsive advance. The broad consolidation seen between August and November fits well as a Wave (4) corrective structure (range-bound and time-consuming). The recent breakout with higher highs and higher lows signals the start of Wave (5) in the larger Elliott Wave cycle. Importantly, this breakout is occurring after sufficient correction, increasing the probability of trend continuation rather than a false move. 2️⃣ Momentum Insight – MACD Behavior During the corrective phase, price drifted lower while downside momentum weakened, indicating a bullish MACD divergence. This divergence laid the groundwork for the current rally. As price broke out, momentum expanded positively, confirming strength. The lack of bearish divergence on the recent highs suggests the move is momentum-backed, not exhaustion-driven. 3️⃣ AVWAP as a Key Institutional Level Anchored VWAP, drawn from the prior major swing high, acted as resistance throughout the consolidation. Glenmark has now reclaimed AVWAP decisively and is sustaining above it, converting it into a strong support zone. This behavior often reflects institutional accumulation and improves the reliability of the breakout structure. 5️⃣ Fundamental Strength Supporting the Chart Fundamentally, Glenmark Pharmaceuticals Limited exhibits healthy ROCE levels and consistent profit growth, indicating efficient capital utilization and business resilience. Such fundamentals provide a strong base for technical breakouts, often allowing trends to extend further than purely speculative moves.